MDNews - Lower Hudson/Bronx

April 2015

Issue link: https://viewer.e-digitaledition.com/i/493486

Contents of this Issue

Navigation

Page 29 of 31

3 0 | Lower Hudson/Bronx MD NEWS ■ M D N E W S . CO M The Nyack Hospital laboratory has been awarded accredita - tion by the College of American Pathologists (CAP) based on the results of a recent on- site inspection. This ac - creditation is awarded to facilities that meet the highest standards of excellence in quality laboratory practices. Nyack Hospital is one of more than 7,600 CAP accredited facili - ties worldwide. The CAP Laboratory Accreditation Program is recognized by the federal government as being equal to or more stringent than the govern - ment's own inspection program. The accreditation process includes inspection of laboratory records and quality control procedures as well as examination of laboratory staff qualifications, equipment, facilities, safety program, and record and overall laboratory management. A growth hormone can significantly improve the social impairment as - sociated with autism spectrum disorder in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published on PubMed, a public database of biomedical topics maintained by the National Institutes of Health. The study was originally published in the Dec. 12 issue of the journal Molecular Autism. The Mount Sinai study is the first to suggest that IGF-1 is safe, tolerable and associated with significant improvement in both social impairment and restrictive behaviors — fascination with one subject or activity; strong attachment to one specific object; preoccupation with part(s) of an object rather than the whole object; preoccupation with movement or things that move — in people with Phelan-McDermid syndrome, said the study authors. This study was funded by that Beatrice and Samuel A. Seaver Foundation and by the National Institute of Mental Health, part of the National Institutes of Health. Local News The Hyperbaric Medicine Center at Phelps Memorial Hospital Center in Sleepy Hollow, New York, recently received accreditation from the Undersea and Hyperbaric Medical Society (UHMS). Accreditation takes place every three years. UHMS is an international non-profit organiza - tion serving more than 2,400 members from more than 50 countries. The UHMS clinical hyperbaric medicine facility accreditation program recognizes hyperbaric facilities that demonstrate their commitment to patient care and facility safety. Areas examined by a UHMS team of ex - perts include staffing and training, equipment installation, operation and maintenance, facility and patient safety, and standards of care. The Icahn School of Medicine at Mount Sinai and LifeMap Solutions, a subsidiary of BioTime (BTX), recently announced the launch of a large- scale medical research study that uses the new ResearchKit framework developed by Apple to make it easy for individuals who suffer from asthma to participate in studies right from their iPhone. The Asthma Health app is designed to facilitate asthma patient edu - cation and self-monitoring, promote positive behavioral changes, and reinforce adherence to treatment plans according to current asthma guidelines. The study tracks symptom patterns and potential triggers in an individual for these exacerbations so that researchers can learn new ways to personalize asthma treatment. ResearchKit is a new software framework designed by Apple that helps doctors and scientists gather data more frequently and more ac - curately from participants using iPhone apps. When granted permission by the user, the Asthma Health app can access health data from HealthKit to track asthma inhaler use measured by third-party devices and apps, or can take advantage of the accelerometer, microphone, gyroscope and GPS sensors built into iPhone to gather other relevant health data. The Asthma Health app is available for download today on the App Store; for more information visit icahn.mssm.edu/asthmaapp. Save the date for a Martin Clearwater & Bell webinar on April 23. The Approach to Opposing Experts webinar will run from 9 a.m.–noon. Martin Clearwater & Bell LLP Partners John Lyddane, Rosaleen McCrory and John Barbera will discuss the approach to opposing ex - perts from a defense lawyer's perspective. Topics will include: + Expert exchange + Limiting the scope of expert testimony + Tactics of dealing with experts at trial This program is approved for three New York State CLE cred- its. To register, email Courtney Scott at scottc@mcblaw.com or call 212-471-1235. ■ (L–R) Assistant Director of Pathology at Nyack Hospital Douglas Charney, MD; Director of Pathology at Nyack Hospital Vandana Hoon, MD; pathologist Bhuvaneswari Dorai, MD

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - April 2015